Rare epithelial tumor of small intestine Advocacy Hub | UniteRare

At a Glance

Live from database

🩺

4Specialists

Regulatory Watchboard

No FDA or trial events recorded yet for Rare epithelial tumor of small intestine.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Lynparza

AstraZeneca Pharmaceuticals LP

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Lynparza

(olaparib)Orphan drugstandard

AstraZeneca Pharmaceuticals LP

Poly(ADP-Ribose) Polymerase Inhibitor [EPC]

12.1 Mechanism of Action Olaparib is an inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, including PARP1, PARP2, and PARP3. PARP enzymes are ...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Rare epithelial tumor of small intestine.
Search all trials →

Search clinical trials for Rare epithelial tumor of small intestine →

Recent News & Research

No recent news articles indexed yet for Rare epithelial tumor of small intestine.
Search PubMed for Rare epithelial tumor of small intestine →

Browse all Rare epithelial tumor of small intestine news →

Specialist Network

Top 4 by expertise

Matthew Krebs, Dr

The Christie Hospital

Score 387 trials

Kanwal P Raghav, M.D

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 92 trials6 pubs

Sandip P Patel

SWOG Cancer Research Network

📍 Birmingham, Alabama

Score 81 trial

Camila MV Moniz, Doctor

Oncologist

📍 SAN ANTONIO, TX

Score 81 trial

View all Rare epithelial tumor of small intestine specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰